Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-18
2008-03-18
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S302700
Reexamination Certificate
active
10969105
ABSTRACT:
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.
REFERENCES:
patent: 6355664 (2002-03-01), Kelly et al.
patent: 6437148 (2002-08-01), Frutos et al.
patent: 6492408 (2002-12-01), Wu et al.
patent: 6689804 (2004-02-01), Wu
patent: 6844360 (2005-01-01), Kelly
patent: WO 98/39303 (1998-09-01), None
patent: WO 01/07440 (2001-02-01), None
Springer, T. A.; “Adhesion receptors of the immune system”; Nature, 1990, 346, pp. 425-434.
Kishimoto, T. K. et al; “Integrins, ICAMs, and Selectins: Role and Regulation of Adhesion Molecules in Neutrophil Recruitment to Inflammatory Sites”; Adv. Pharmacol. 1994, 25, pp. 117-138.
Diamond, M.S.; “The dynamic regulation of integrin adhesiveness”; Current Biology, 1994, 4, pp. 506-517.
Anderson, D.C. et al; “Leukocyte LFA-1, OKM1, p150,95 deficiency syndrome: functional and biosynthetic studies of three kindreds1,2”; Fed. Proc. 1985, 44, pp. 2671-2677.
Anderson, D.C. et al; “The Severe and Moderate Phenotypes of Heritable Mac-1,LFA-1 Deficiency: Their Quantitative Definition and Relation to Leukocyte Dysfunction and Clinical Features”; J Infect Dis., 1985, 152, pp. 668-689.
Gorski, A.; “The role of cell adhesion molecules in immunopathology”; Immunology Today, 1994, 15, pp. 251-255.
Rothlein, R. et al; “1. Leukocyte Adhesion in Inflammation: From Discovery to the Clinic”; Adhesion Molecules; Wegner, C. D., ed.; 1994, pp. 1-8.
Cosimi, A.B. et al; “In Vivo Effects Of Monoclonal Antibody To ICAM-1 (CD54) In Nonhuman Primates With Renal Allografts1”; J. Immunol. 1990, 144, pp. 4604-4612.
Kavanaugh, A. F. et al; “Treatment of Refractory Rheumatoid Arthritis With A Monoclonal Antibody To Intercellular Adhesion Molecule 1”; Arthritis Rheum. 1994, 37, pp. 992-1004.
Fischer, A. et al; “Prevention of Graft Failure By An Anti-HLFA-1 Monoclonal Antibody In HLA-Mismatched Bone-Marrow Transplantation”; Lancet, 1989, 2, pp. 1058-1060.
LeMauff, B. et al; “Effect of Anti-LFA1 (CD11a) Monoclonal Antibodies In Acute Rejection In Human Kidney Transplantation”; Transplantation, 1991, 52, pp. 291-295.
Becker, J. C. et al; “Soluble Intercellular Adhesion Molecule-1 Inhibits MHC-Restricted Specific T Cell/Tumor Interation”; J. Immunol., 1993, 151, pp. 7224-7232.
Roep, B. O., et al; “Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus”; Lancet, 1994, 343, pp. 1590-1593.
Bowcock, et al; Getting Under the Skin: The Immunogenetics of Psoriasis; Nature Reviews Immunology; Sep. 2005; vol. 5; pp. 699-711; Nature Publishing Group.
Gottlieb; Psoriasis: Emerging Therapeutic Strategies; Nature Review Drug Discovery; Jan. 2005; vol. 4; pp. 19-34.
Kelly, et al; Cutting Edge: A Small Molecule Antagonist of LFA-1-Mediated Cell Adhesion; The Journal of Immunology; 1999; vol. 163; pp. 5173-5177.
Last-Barney, et al; Binding Site Elucidation of Hydantoin-Based Antagonists of LFA-1 Using Multidisciplinary Technologies: Evidence for the Allosteric Inhibition of a Protein-Protein Interaction; Journal of American Chemical Society; 2001; vol. 123; pp. 5643-5650.
Wu, et al; Second-Generation Lymphocyte Function-Associated Antigen-1 Inhibitors: 1H-Imidazol[1,2-a]imidazol-2-one Derivatives; Journal of Medicinal Chemistry; 2004; vol. 47; pp. 5356-5366.
Kelly Terence Alfred
Kim Jin Mi
Lemieux René Marc
Boehringer Ingelheim Pharmaceuticals Inc.
Chong Yong S.
Datlow Philip I.
Devlin Mary-Ellen M.
Morris Michael P.
LandOfFree
Derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3932416